"I was never like that": Australian findings on the psychological and psychiatric sequelae of corticosteroids in haematology treatments.
OBJECTIVE
Corticosteroid treatments have been well documented to cause severe emotional and even psychiatric disturbances. Despite that corticosteroid use is at the core of most treatment protocols for haematological malignancies, there is a dearth of published research (and controversy in the existing research) on the emotional and psychiatric sequelae of corticosteroid use for haematology patients and its connection with pre-existing mental history. This paper aims to address this hiatus and confusion by examining the emotional and psychiatric side effects of corticosteroids on haematology patients in Australia.


METHODS
The findings are from a pilot study that explored the prior mental health history and effects of corticosteroid use of ten haematology patients in Australia. Data was collected through an iterative, phenomenological, qualitative research methodology using open-ended interviews conducted at the time and location of the participant's choice. The interviews were audio-recorded and transcribed verbatim. The language texts were then entered into the QSR NUD*IST computer program and analysed thematically.


RESULTS
The significant finding from the study was that corticosteroids used in haematology treatments have the potential to affect anyone and are not related to an individual's prior mental health history. No participant presented evidence of psychiatric history or counseling and many reported emotional stability during previous times of difficulty. All participants reported emotional distress directly related to corticosteroid use. Participants reported difficulties during the period of withdrawal from corticosteroids and relief during periods free from the administration of corticosteroids.


CONCLUSIONS
The findings provide evidence that emotional disturbances associated with corticosteroid use in haematology are a direct result of the drugs used and not a symptom of the individual's prior emotional health. Recommendations are given which have important implications for the management, support and education of patients and their families in relation to the potential emotional side effects from steroid administration and withdrawal.
McGrath
Pam
P
International Program of Psycho-Social Health Research, Central Queensland University, P.O. Box 1307, Kenmore, Brisbane, Queensland 4069, Australia. pam_mcgrath@bigpond.com
Patton
Mary Anne
MA
James
Sarah
S
D000328:Adult; D000368:Aged; D001315:Australia / Q000453:epidemiology; D003625:Data Collection; D003907:Dexamethasone / Q000009:adverse effects / Q000627:therapeutic use; D004644:Emotions / Q000187:drug effects*; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects* / Q000627:therapeutic use; D006402:Hematologic Diseases / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011239:Prednisolone / Q000009:adverse effects / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome / Q000523:psychology*; D055815:Young Adult
D005938:Glucocorticoids; D003907:Dexamethasone; D011239:Prednisolone